“Disruptive products require disruptive channels” – Christensen and Raynor, The Innovator’s Solution
The importance of distribution channels is often overlooked when analyzing the evolution of disruptive technologies, however, few truly disruptive companies grow through traditional distribution channels. In many cases, the growth of the disruptive distribution channel paves the way for disruptive companies – allowing them to bloom by reaching non-traditional customers and eventually changing the way their industries work.
Japanese bioprinting firm, Cyfuse Biomedical, raises $11.7 million Series B; The intelligent money is on 3D printing of electronics
On 2 March, Cyfuse Biomedical K.K. announced they had completed a 1.4 billion JPY (approximately $11.7 million USD) Series B funding round, with participation from 12 investors, including venture capital funds and corporate investors as well as government support. The Japanese BioPrinting firm has now raised a total of 1.98 billion JPY, which includes a 422 million JPY (approximately $4.77 million USD) Series A back in January 2013.